The PROGRESS trial three years later: time for more action, less distraction
- PMID: 15499117
- PMCID: PMC524115
- DOI: 10.1136/bmj.329.7472.970
The PROGRESS trial three years later: time for more action, less distraction
Erratum in
- BMJ. 2004 Nov 6;329(7474):1073
Figures
Comment in
-
Perindopril monotherapy and PROGRESS in Europe.BMJ. 2005 Jul 23;331(7510):235-6. doi: 10.1136/bmj.331.7510.235-b. BMJ. 2005. PMID: 16037473 Free PMC article. No abstract available.
-
ASCOT: a tale of two treatment regimens: odds are that it's hype.BMJ. 2005 Oct 29;331(7523):1022-3. doi: 10.1136/bmj.331.7523.1022-b. BMJ. 2005. PMID: 16254307 Free PMC article. No abstract available.
Comment on
-
Secondary prevention for stroke and transient ischaemic attacks.BMJ. 2004 Feb 7;328(7435):297-8. doi: 10.1136/bmj.328.7435.297. BMJ. 2004. PMID: 14764462 Free PMC article. No abstract available.
-
The PROGRESS trial three years later: time for a balanced report of effectiveness.BMJ. 2004 Oct 23;329(7472):968-70. doi: 10.1136/bmj.329.7472.968. BMJ. 2004. PMID: 15499116 Free PMC article.
References
-
- PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358: 1033-41. - PubMed
-
- PROGRESS Collaborative Group. Effects of a perindopril-based blood pressure lowering regimen on disability and dependency in 6105 patients with cerebrovascular diseases. Stroke 2003;34: 2333-8. - PubMed
-
- PROGRESS Collaborative Group. Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. Eur Heart J 2002;24: 475-84. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical